Picornavirus Identified in Alzheimer's Disease Brains: A Pathogenic Path?

被引:9
|
作者
Niklasson, Bo [1 ]
Lindquist, Lars [2 ]
Klitz, William [3 ]
Bank, Netherlands Brain [4 ]
Englund, Elisabet [5 ]
机构
[1] Jordbro Primary Hlth Care Ctr, S-13764 Stockholm, Sweden
[2] Karolinska Inst, Dept Med Huddinge, Div Infect Dis, Stockholm, Sweden
[3] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA
[4] Netherlands Inst Neurosci, Netherlands Brain Bank, Amsterdam, Netherlands
[5] Lund Univ, Dept Clin Sci, Div Pathol, Lund, Sweden
关键词
Alzheimer's disease; immunohistochemistry; Ljungan virus; neurodegenerative disease; picornavirus; ZOONOTIC LJUNGAN VIRUS; IMMUNOHISTOCHEMISTRY; DEMENTIA; PROTEIN; SYSTEM; DEATH; TAU;
D O I
10.3233/ADR-200174
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated formalin-fixed postmortem brain tissue from the hippocampus region of 18 AD cases and 11 age-matched controls using a polyclonal antibody against Ljungan virus (LV) capsid protein 1. Evidence of a LV antigen was found in all AD cases but in none of the control specimens (p < 0.0001). The antibodies reacted with neurons and astrocytes and also showed distinct positive reaction in the amyloid/neuritic plaques. The possible role of an incompletely characterized picornavirus as the etiologic agent in AD open up the possibility of treatment with antiviral therapy directed against picornaviruses. The positive result of such treatment in a small number of patients is presented separately back to back to this report.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 50 条
  • [1] Gephyrin Plaques Identified in Frontal Cortex of Alzheimer's Disease Brains
    Hales, Chadwick M.
    Rees, Howard
    Lah, James J.
    Levey, Allan I.
    Wingo, Thomas
    ANNALS OF NEUROLOGY, 2012, 72 : S43 - S43
  • [2] New plaque protein identified in brains of people with Alzheimer's disease
    Larkin, M
    LANCET, 1997, 350 (9070): : 36 - 36
  • [3] Glycolysis in the brains of patients with Alzheimer's disease
    Bigl, M
    Bleyl, A
    Eschrich, K
    Bigl, V
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S44 - S44
  • [4] Substantia nigra in Alzheimer's disease brains
    da Silva, K.
    Eschbach, D. -A.
    Juenemann, M. B. T.
    Kuchelmeister, K.
    ACTA NEUROPATHOLOGICA, 2008, 116 (03) : 354 - 354
  • [5] Quantification of hemorphins in Alzheimer's disease brains
    Poliak, A
    McLean, CA
    Sachdev, P
    Brodaty, H
    Smythe, GA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (05) : 704 - 714
  • [6] Glycolysis in the brains of patients with Alzheimer's disease
    Bigl, M
    Brückner, MK
    Arendt, T
    Eschrich, K
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S24 - S24
  • [7] Modeling Alzheimer's disease brains in vitro
    Henstridge, Christopher M.
    Spires-Jones, Tara L.
    NATURE NEUROSCIENCE, 2018, 21 (07) : 899 - 900
  • [8] Metabolic profiling of Alzheimer's disease brains
    Inoue, Koichi
    Tsutsui, Haruhito
    Akatsu, Hiroyasu
    Hashizume, Yoshio
    Matsukawa, Noriyuki
    Yamamoto, Takayuki
    Toyo'oka, Toshimasa
    SCIENTIFIC REPORTS, 2013, 3
  • [9] Metabolic profiling of Alzheimer's disease brains
    Koichi Inoue
    Haruhito Tsutsui
    Hiroyasu Akatsu
    Yoshio Hashizume
    Noriyuki Matsukawa
    Takayuki Yamamoto
    Toshimasa Toyo'oka
    Scientific Reports, 3
  • [10] Modeling Alzheimer’s disease brains in vitro
    Christopher M. Henstridge
    Tara L. Spires-Jones
    Nature Neuroscience, 2018, 21 : 899 - 900